ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

Saved in:
Bibliographic Details
Title: ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
Authors: Heyza JR; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Ekinci E; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Lindquist J; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Lei W; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Yunker C; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Vinothkumar V; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Rowbotham R; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Polin L; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Snider NG; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Van Buren E; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Watza D; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Back JB; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Chen W; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Mamdani H; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Schwartz AG; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Turchi JJ; Departments of Medicine and Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.; NERx Biosciences, Indianapolis, IN, USA., Bepler G; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA., Patrick SM; Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA.
Source: NAR cancer [NAR Cancer] 2023 Jan 11; Vol. 5 (1), pp. zcac045. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-8674
DOI:10.1093/narcan/zcac045